| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 301108 | 洁雅股份 | 27.05 | -4.11% | 4.92万 | 1.35亿 | | 603193 | 润本股份 | 34.45 | -4.04% | 19.96万 | 6.96 Z | | 002511 | 中顺洁桑 | 7.66 | -2.67% | 53.20万 | 4.16 亿 | | 001206 | 依依股份 | 25.36 | -2.54% | 6.76万 | 1.72亿 | | 605009 | 豪倪护理 | 40.56 | -2.08% | 8.71万 | 3.62亿 | | 603238 | 诺邦股份 | 19.13 | -1.65% | 21.21万 | 4.32亿 | | 003006 | 百亚股份 | 26.97 | -1.21% | 7.48万 | 2.03亿 | | 300888 | 稳健医疗 | 40.82 | -1.02% | 9.16万 | 3.77亿 | | 600249 | 两面针 | 5.8 ...

Investment Rating - The report maintains an "Overweight" rating for the industry, with a focus on new consumption sectors such as beauty care, IP derivatives, and gold jewelry [5][29]. Core Insights - The beauty care sector is highlighted with the launch of the world's first "honeycomb collagen" gel product by Jinbo Biological, which shows significant advancements in cell adhesion and collagen retention [3][23]. - The report notes a general increase in the performance of retail, social services, and beauty care sectors, with respective weekly gains of +2.65%, +2.30%, and +5.42% [14][16]. - Key companies such as Proya and Huaxi Hospital are collaborating on mitochondrial anti-aging research, indicating a trend towards scientific advancements in beauty products [3][23]. Summary by Sections Market Performance - For the week of July 21-25, 2025, the retail, social services, and beauty care sectors saw increases of +2.65%, +2.30%, and +5.42%, ranking 14th, 17th, and 6th among 31 primary industries [14][16]. - Sub-sectors such as personal care products, tourism, and cosmetics experienced notable gains of +7.74%, +3.93%, and +3.39% respectively [16][19]. Key Industry Events and News - The National Development and Reform Commission announced that the Hainan Free Trade Port will officially close on December 18, 2025, which is expected to enhance trade conditions [3][23]. - Jinbo Biological launched a new injectable collagen gel product, which is expected to significantly improve skin treatment outcomes [3][23]. - Proya and Huaxi Hospital have partnered to focus on mitochondrial anti-aging research, which may lead to innovative product developments [3][23]. Investment Recommendations - The report recommends focusing on companies within the beauty care, IP derivatives, and gold jewelry sectors, suggesting specific stocks such as Proya, Giant Biological, and Marubi [5][29]. - The report emphasizes the potential for growth in these sectors, particularly in light of recent product innovations and market trends [5][29].

Company Overview - Tongling Jeya Biotechnology Co., Ltd. was established in 1999, specializing in the research, production, and sales of wet wipes, with over 20 years of industry experience [2]. - The company was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on December 3, 2021, and is steadily advancing its fundraising projects [2]. Financial Performance - In Q1 2025, the company reported a revenue of 124 million yuan and a net profit of 10.06 million yuan [2]. Business Operations - As of Q2 2025, the company has a stable order flow in its wet wipes business, with existing customers in Europe and Canada [3]. - The current production capacity utilization rate is approximately 80% [3]. - The U.S. wet wipes factory is under construction and is expected to commence production next year, primarily serving international brand clients in the North American market [3]. Clientele and Market Expansion - Key clients in the wet wipes business include international brands such as Woolworths, Kimberly-Clark, Johnson & Johnson, Procter & Gamble, as well as domestic e-commerce brands like Babycare and Dongfang Zhenxuan [3]. - The company anticipates that overseas orders will increase, with foreign sales expected to account for over 50% of total business in 2025 [3]. Risk Management - Investment risks associated with the U.S. factory include uncertainties in facility renovation and approval processes, customer audit outcomes, potential delays in production timelines, and cultural differences affecting production efficiency [3]. Future Business Strategy - The company plans to expand its cosmetics business, primarily through contract manufacturing for L'Oréal, while also exploring domestic clients [4]. - The current revenue from proprietary brands is low, with a focus on contract manufacturing [4]. - Future business drivers include expanding existing brand client relationships and leveraging the new U.S. factory [4]. Stock Performance - The company's stock price fluctuations are influenced by macroeconomic factors, industry policies, and market sentiment, with no undisclosed significant information affecting operations as of the date of the meeting [4].

Core Viewpoint - The company, Jieya Co., Ltd., faces internal dissent regarding its 2025 restricted stock incentive plan, with significant opposition from non-independent director Yu Yancheng, who argues that the plan is overly conservative and misaligned with the interests of minority shareholders [1][4]. Group 1: Incentive Plan Details - The incentive plan proposes to grant a total of 1.82 million restricted shares, with an initial grant price of 12.63 yuan per share, significantly lower than the company's net asset value of 22.86 yuan per share [1][4]. - The plan includes 10 recipients, including 4 senior executives, who collectively will receive 700,000 shares valued at over 18.8 million yuan based on the closing price of 26.92 yuan per share on July 22 [1][2]. Group 2: Performance Assessment Criteria - The performance assessment for the restricted stock grants spans from 2025 to 2027, requiring revenue growth rates of at least 25%, 50%, and 100% for the respective years [3][6]. - The company previously launched an incentive plan in 2022, which set revenue growth targets of at least 10%, 30%, and 50% for the years 2023 to 2025, but failed to meet these targets, resulting in the cancellation of unvested shares [5][7]. Group 3: Historical Context and Stakeholder Concerns - Yu Yancheng, who has been with the company in various capacities since 2012, expressed concerns that the current plan's structure and timing do not align with shareholder interests, particularly for minority shareholders [3][4]. - The company has a history of overlapping performance targets between different incentive plans, leading to confusion and potential conflicts in revenue assessment for the same fiscal year [5][7].

Group 1 - On July 21, a total of 13 companies were investigated by institutions, with 8 companies being surveyed by funds, highlighting a significant interest in Zhejiang Fu Holdings, which had 14 participating funds [1] - Other companies that attracted attention included Jieya Co., which had 9 funds participating, and Chutianlong, which had 6 funds involved in the survey [1] - Among the surveyed companies, 4 were from the Shenzhen main board and 4 from the ChiNext board, indicating a balanced interest across different market segments [2] Group 2 - The total market capitalization of the surveyed companies included 4 with a market cap of less than 10 billion yuan, specifically Jieya Co., Yuningwei, and Aidi Te [2] - In terms of market performance, 7 out of the surveyed stocks increased in value over the past 5 days, with North Chemical Co. leading at a rise of 32.77%, followed by Suzhou Tianmai at 23.93% and Zhejiang Fu Holdings at 11.48% [2] - Only one stock, Chutianlong, experienced a decline, with a drop of 6.85% [2] Group 3 - Among the surveyed companies, only 2 released half-year performance forecasts, with one company expecting an increase in net profit [2] - North Chemical Co. is projected to have the highest net profit growth, with an expected median net profit of 105 million yuan, representing a year-on-year increase of 201.48% [2]

Group 1 - The beauty care sector experienced a significant rise at the beginning of trading, with Jeya Co., Ltd. (301108) increasing by over 10% [1] - Yiyi Co., Ltd. (001206) approached the daily limit increase, indicating strong market interest [1] - Aimeike (300896) saw an increase of over 4%, reflecting positive sentiment in the industry [1] Group 2 - Other companies such as Shuiyang Co., Ltd. (300740) and Shanghai Jahwa United Co., Ltd. (600315) also experienced upward movement, suggesting a broader trend in the beauty care sector [1]

Core Viewpoint - The company is set to implement a restricted stock incentive plan for 2025, which is deemed beneficial for its long-term development and aligns with the interests of shareholders [1][4]. Group 1: Eligibility and Conditions - The company has the necessary qualifications to implement the incentive plan, ensuring that the incentive objects meet the legal and regulatory requirements [2]. - Specific prohibitive conditions for implementing the stock incentive plan include negative audit opinions on financial reports and failure to distribute profits according to legal and regulatory standards [1][2]. Group 2: Incentive Objects - The incentive plan targets directors, senior management, core technical and business personnel, and other employees who directly impact the company's performance, excluding foreign personnel and major shareholders [2][3]. Group 3: Disclosure and Approval Process - The company must publicly disclose the names and positions of the incentive objects for at least 10 days before the shareholders' meeting, allowing for feedback on the proposed list [3]. - The plan requires approval from the shareholders' meeting before implementation, ensuring compliance with relevant laws and regulations [3][4]. Group 4: Strategic Alignment - The incentive plan is designed to create a shared interest between employees and shareholders, enhancing management efficiency and supporting the company's sustainable development [4].

Group 1 - The company held its sixth board meeting on July 21, 2025, via communication, with 9 directors expected to attend and all legal requirements met [1] - The board approved the draft of the 2025 Restricted Stock Incentive Plan to attract and retain talent, enhance the incentive effect, and promote long-term stable development [1][2] - The plan requires approval from the shareholders' meeting, needing more than two-thirds of the voting rights to pass [2][6] Group 2 - The board proposed to authorize the board to manage the implementation of the 2025 Restricted Stock Incentive Plan, including determining eligibility and adjusting stock grants based on corporate actions [4][5] - The board's decision on the incentive plan received 3 votes in favor and 1 against, with the dissenting director citing concerns over the timing and conservativeness of the plan [2][6][8] - The company plans to hold a temporary shareholders' meeting on August 8, 2025, to discuss the incentive plan and other matters [7]

Meeting Information - The company will hold its fourth extraordinary general meeting of shareholders on August 8, 2025, at 14:30 [1] - Network voting will also take place on the same day, with specific time slots for voting through the Shenzhen Stock Exchange trading system and internet voting system [1][2] Voting Procedures - Shareholders can choose to attend the meeting in person or authorize a representative to attend [2] - Network voting is available through the Shenzhen Stock Exchange trading system and internet voting system, with detailed procedures provided [5][7] Agenda Items - The meeting will review several proposals, including the draft of the 2025 Restricted Stock Incentive Plan and related matters [3][4] - Proposals 1 to 3 require a special resolution, needing more than two-thirds of the votes from attending shareholders [4] Registration and Attendance - The record date for shareholders to attend the meeting is August 4, 2025, and those holding shares on this date are eligible to participate [4] - Specific registration procedures are outlined for both individual shareholders and authorized representatives [4][6] Additional Information - The company will separately count votes from minority investors, defined as shareholders excluding directors, senior management, and those holding more than 5% of shares [4] - The company has provided a detailed voting process for shareholders participating via the internet [5][7]

证券代码：301108 证券简称：洁雅股份 公告编号：2025-054 铜陵洁雅生物科技股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、担保情况概述 铜陵洁雅生物科技股份有限公司（以下简称"公司"或"洁雅股份"）于 2025 年 7 月 21 日召开第六届董事会第二次会议，审议通过了《关于为参股公司提供担 保暨关联交易的议案》。本事项已经公司独立董事专门会议审议通过。 根据业务发展需要，公司参股公司赛得利（铜陵）无纺材料有限公司（以下 简称"赛得利铜陵"）拟向银行申请总额度为 3000 万元的贷款，贷款期限为三年。 公司及其他各方股东拟按各自持股比例提供担保，公司持有赛得利铜陵 20%的股 权，赛得利（九江）纤维有限公司（以下简称"赛得利九江"）持有赛得利铜陵 式为连带责任担保，担保期限以与银行签署的协议为准，其余股东按照持股比例 为赛得利铜陵提供担保。 公司董事长兼总经理蔡英传先生在赛得利铜陵担任董事，公司董事兼财务总 监杨凡龙先生在赛得利铜陵担任监事。根据《深圳证券交易所创业板股票上市规 则》的规定，赛得利铜陵为公司的关联法人。本次公司与 ...